BECTON, DICKINSON AND COMPANY Restricted Cash and Investments, Current
BECTON, DICKINSON AND COMPANY (BDX) had Restricted Cash and Investments, Current of $155.00 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashAndInvestmentsCurrent · last filed 2026-08-06
- 2026-06-30: Restricted Cash and Investments, Current $155.00M.
- 2026-03-31: Restricted Cash and Investments, Current $202.00M.
- 2025-12-31: Restricted Cash and Investments, Current $284.00M.
- 2025-09-30: Restricted Cash and Investments, Current $210.00M.
| Period end | Restricted Cash and Investments, Current |
|---|---|
| 2026-06-30 | $155.00M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $202.00M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $284.00M 10-Q · filed 2026-02-09 |
| 2025-09-30 | $210.00M 10-Q · filed 2026-08-06 |
| 2025-06-30 | $62.00M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $80.00M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $102.00M 10-Q · filed 2025-02-06 |
| 2024-09-30 | $139.00M 10-K · filed 2025-11-25 |
| 2024-06-30 | $28.00M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $46.00M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $54.00M 10-Q · filed 2024-02-01 |
| 2023-09-30 | $65.00M 10-K · filed 2024-11-27 |
| 2023-06-30 | $101.00M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $87.00M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $133.00M 10-Q · filed 2023-02-02 |
| 2022-09-30 | $153.00M 10-K · filed 2023-11-21 |
| 2022-06-30 | $202.00M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $173.00M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $144.00M 10-Q · filed 2022-02-03 |
| 2021-09-30 | $109.00M 10-K · filed 2022-11-22 |
| 2021-06-30 | $128.00M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $164.00M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $199.00M 10-Q · filed 2021-02-04 |
| 2020-09-30 | $92.00M 10-K · filed 2021-11-24 |
| 2020-06-30 | $82.00M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $88.00M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $49.00M 10-Q · filed 2020-02-06 |
| 2019-09-30 | $54.00M 10-K · filed 2020-11-25 |
| 2019-06-30 | $71.00M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $81.00M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $98.00M 10-Q · filed 2019-02-05 |
| 2018-09-30 | $96.00M 10-K · filed 2019-11-27 |
| 2018-06-30 | $125.00M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $167.00M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $113.00M 10-Q · filed 2018-02-06 |
| 2017-09-30 | $0.00 10-K · filed 2018-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |